#12 Regulatory Landscape of Biologics

The Bone Beat

#12 Regulatory Landscape of Biologics

David Jevsevar, MD, MBA, FAAOS, Chair of the Committee on Devices, Biologics & Technology and Raymond Golish, MD, PhD, MBA, FAAOS, Member of the Committee on Devices, Biologics & Technology
November 24, 2020

#12 Regulatory Landscape of Biologics

Biologics are increasingly being marketed and used to improve outcomes for orthopaedic patients, but the requirements for evidence of safety and effectiveness vary greatly. Leaders from the AAOS Committee on Devices, Biologics & Technology discuss the regulatory landscape, the AAOS Biologics Initiative, and the Academy’s investment in this evolving area of medicine, They also explain how the new AAOS Biologics Dashboard is designed to help members navigate the approval status of biologic-based interventions. Learn more about the AAOS Biologics Initiative and access the dashboard.


Hosted by:

Kristen Coultas, AAOS Advocacy Communications Director 

You may also like

Top Health Podcasts. Delivered to Your Inbox and Eardrums.

Proudly supported by:

Cultivating Resilience During Times of Crisis and Existential Threat Keith interviews Dr. Chris Recinos, the CEO and founder of Nurse Leader Network, regarding mental health, adaptive and maladaptive mechanisms of resilience, and conscious self-development.